Tricyanoaminopropene

Tricyanoaminopropene
Clinical data
Trade names Triap
Legal status
Legal status
  • Investigational
Identifiers
CAS Number 868-54-2 YesY
PubChem (CID) 13356
ECHA InfoCard 100.011.616
Chemical and physical data
Formula C6H4N4
Molar mass 132.123 g/mol
3D model (Jmol) Interactive image
  (verify)

Tricyanoaminopropene (TRIAP, TCAP, Malononitrile Dimer, 1,1,3-tricyano-2-amino-1-propene) is a nootropic drug which mimics the function of nerve growth factor and increases the growth of nerves and tissue regeneration both in isolated tissues[1] and in vivo. It stimulates the action of the enzyme choline acetyltransferase, resulting in increased acetylcholine production.[2] This then results in increased synthesis of RNA in many different tissues in the body.[3] However it also suppresses the production of thyroxine, causing temporary hypothyroidism which returns to normal once the drug is discontinued.[4]

Tricyanoaminopropene reduces the amnesia produced by electroconvulsive shock,[5] and animal tests suggested nootropic activity,[6][7][8] but no beneficial effect was found when it was tested in mentally retarded children,[9] and administration to pregnant rats actually reduced learning ability in their young because of its anti-thyroid hormone effects.[10] This drug thus produces two effects which oppose each other, with the nootropic effect from the increased acetylcholine production cancelled out by the opposite effect produced by the decrease in production of thyroxine. It is not known whether the efficacy of the drug could be improved by supplementation with additional thyroxine or equivalent drugs.

See also

References

  1. ↑ Paul JW, Quach TT, Duchemin AM, Schrier BK, DaVanzo JP. 1,1,3 tricyano-2-amino-1-propene (Triap): a small molecule which mimics or potentiates nerve growth factor. Brain Research. Developmental Brain Research. 1990 Aug 1;55(1):21-7. PMID 2208638
  2. ↑ Paul JW, DaVanzo JP. 1,1,3 Tricyano-2-amino-1-propene (Triap) stimulates choline acetyltransferase activity in vitro and in vivo. Brain Research. Developmental Brain Research. 1992 Jun 19;67(2):113-20. PMID 1511511
  3. ↑ Dhindsa KS, Enesco HE. Radioautographic study of the effect of malononitrile dimer on RNA synthesis in mice. Acta Anatomica (Basel). 1978;100(1):44-50. PMID 899675
  4. ↑ Dhindsa KS. Histological changes in the thyroid gland of the mouse following treatment with 1, 1, 3-tricyano-2-amino-1-propene. Acta Anatomica (Basel). 1980;106(4):468-72. PMID 7386168
  5. ↑ Essman WB. Effect of tricyanoaminopropene on the amnesic effect of electroconvulsive shock. Psychopharmacology (Berlin. 1966 Jan;9(5):426-433 doi:10.1007/BF00406452.
  6. ↑ Rahwan RG. The biochemical and pharmacological basis of learning and memory. Inflammation Research. 1971 Aug;2(2):87-102.
  7. ↑ Banfi S, Cornelli U, Fonio W, Dorigotti L. A screening method for substances potentially active on learning and memory. Journal of Pharmacological Methods. 1982 Dec;8(4):255-63. PMID 7154677
  8. ↑ STUDIES OF THE EFFECTS OF MANIPULATION OF BRAIN METABOLISM ON LEARNING. I. VITAMIN B12. II. MAGNESIUM PEMOLINE (CYLERT). III. MALONONITRILE DIMER (U9189). IV. ANODAL POLARIZATION.
  9. ↑ Panzer JD, Atkinson WH. Tricyanoaminopropene (TCAP): Lack of Improvement of Mentation in Mentally Retarded Children. Psychosomatics. 1969 Mar-Apr;10(2):136-40. PMID 4181970
  10. ↑ Davenport JW. Cretinism in Rats: Enduring Behavioral Deficit Induced by Tricyanoaminopropene. Science 1970 Feb;167(3920):1007-1009.
This article is issued from Wikipedia - version of the 10/18/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.